Association of melanoma and natalizumab therapy in the Italian MS population: a second case report

Autor:	Alice Laroni, M. Bedognetti, Elisabetta Capello, Antonio Uccelli, Gianluigi Mancardi
Jazyk:	angličtina
Rok vydání:	2011
Předmět:	Adult medicine.medical_specialty Multiple Sclerosis complications Population Dermatology Antibodies Monoclonal Humanized Antibodies Natalizumab Internal medicine Pharmacovigilance Monoclonal medicine Humans In patient education Adverse effect neoplasms Humanized Melanoma education.field_of_study business.industry Antibodies Monoclonal Adult Antibodies Humanized Antibodies therapeutic use Female Humans Melanoma drug therapy Multiple Sclerosis General Medicine medicine.disease Surgery drug therapy Psychiatry and Mental health therapeutic use Female Neurology (clinical) business medicine.drug
Popis:	There is debate about a possible association between natalizumab treatment and higher risk of melanoma. Here we report a case of melanoma in a patient who developed melanoma after 77 infusions of natalizumab, without known risk factors. Pharmacovigilance programs of new drugs can help to monitor adverse events in patients at risk.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2dd6f886d69997a09e390e4b80e7064 https://hdl.handle.net/11567/293802 Zobrazit plný text záznamu